1.
Capsaicin, resiniferatoxin and botulinum toxin-A – a trip down memory lane
by Dasgupta, Prokar
BJU international, May 2015, Vol.115(5), pp.675
2.
Structure–activity relationships of the ultrapotent vanilloid resiniferatoxin (RTX): The side chain benzylic methylene
by Appendino, Giovanni
Bioorganic & Medicinal Chemistry Letters, 2010, Vol.20(1), pp.97-99
3.
Why do some like it hot? Genetic and environmental contributions to the pleasantness of oral pungency
by Törnwall, Outi
Physiology & Behavior, 10 October 2012, Vol.107(3), pp.381-389
4.
Sequential Events during Capsaicin-Induced TRPV1 Activation
by Xiao, Xian
Biophysical Journal, Feb 16, 2016, Vol.110(3), p.286a
5.
Understanding the Molecular Determinants of Capsaicin Mode of Action
by Elokely, Khaled M.
Biophysical Journal, Jan 27, 2015, Vol.108(2), p.57a
6.
Tu1145 Effects of Esophageal Capsaicin Instillation on Acid Induced Excitation of Secondary Peristalsis in Humans
by Chen, Chien-Lin
Gastroenterology, 2015, Vol.148(4), pp.S-802
7.
Flupirtine inhibits calcitonin-gene related peptide release from rat brainstem in vitro.(Report)
by Tringali, Giuseppe
Neuroscience Letters, Jan 11, 2012, Vol.506(2), p.332(4)
8.
Disparate Effects of Gastric Capsaicin on the Rectal Component of the Gastrocolonic Response
by Fuhrer, Martina
Gastroenterology, 2017, Vol.152(5), p.S920
9.
C-fibers, but not the transient potential receptor vanilloid 1 (TRPV1), play a role in experimental allergic airway inflammation
by Rogerio, Alexandre P
European Journal of Pharmacology, 15 July 2011, Vol.662(1-3), pp.55-62
10.
Use and limitations of three TRPV-1 receptor antagonists on smooth muscles of animals and man: A vote for BCTC
by Benko, Rita
European Journal of Pharmacology, 05 January 2012, Vol.674(1), pp.44-50
11.
Distinct neural representations of placebo and nocebo effects.
by Freeman, Sonya
NeuroImage, May 15, 2015, Vol.112, pp.197-207
12.
Molecular Mechanism of TRPV1 Activation by Capsaicin
by Yang, Fan
Biophysical Journal, Jan 27, Vol.108(2), p.124a
13.
Preparation and Evaluation of PLGA Coated Capsaicin Magnetic Nanoparticles for Target Site-Specific Pain Therapeutics
by Baskaran, Mrudhula
Biophysical Journal, Jan 27, Vol.108(2), p.125a
14.
Pungency of TRPV1 agonists is directly correlated with kinetics of receptor activation and lipophilicity
by Ursu, Daniel
European Journal of Pharmacology, 2010, Vol.641(2), pp.114-122
15.
Capsaicin-Pflaster bei CRPS Typ II
by Husstedt, I.W.
Der Schmerz, Sept, 2013, Vol.27(5), p.517(4)
16.
Recent advances in the study on capsaicinoids and capsinoids
by Luo, Xiu-Ju
European Journal of Pharmacology, 2011, Vol.650(1), pp.1-7
17.
Activity-dependent targeting of TRPV1 with a pore-permeating capsaicin analog
by Li , Hui
2011
Proceedings of the National Academy of Sciences of the United States of America, 2011, Vol.108(20), pp.8497-8502
2011
18.
Discovery of potent, soluble and orally active TRPV1 antagonists. Structure-activity relationships of a series of isoxazoles.
by Ratcliffe, Paul
Bioorganic & medicinal chemistry letters, August 1, 2011, Vol.21(15), pp.4652-4657
19.
Original article: natural capsaicinoids improve swallow response in older patients with oropharyngeal dysphagia.(Report)
by Rofes, Laia
Gut, Sept, 2013, Vol.62(9), p.1280(8)
20.
Effect of dihydrocapsiate on resting metabolic rate in humans.
by Galgani, Jose E
The American journal of clinical nutrition, November 2010, Vol.92(5), pp.1089-1093
